In contrast, the TRIP-Br2 KO mice fed a LFD showed a trend toward improved insulin sensitivity and a mild metabolic phenotype probably due to an insignificant reduction in their body weights ( Fig. 1g , Supplementary Fig. 8 , Supplementary Fig. 9a, 9b ).
← all excerpts
Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance.
1
—
—